Cardioprotective Effect of Resveratrol and Resveratroloside

Author(s): Sergey E. Naumenko , Tatiana V. Latysheva , Michael A. Gilinsky , Artem D. Rogachev , Nina I. Komarova , Nariman F. Salakhutdinov , Genrikh A. Tolstikov .

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry

Volume 11 , Issue 3 , 2013

Become EABM
Become Reviewer


Cardioprotective effect of resveratrol and resveratroloside was determined in ischemia-reperfusion experiments on rats. It was found that single intraperitoneal administration of any compound (10 mg/kg) followed by 30-min ischemia and 120-min reperfusion resulted in statistically significant decrease of myocardial infarct area (55.0±4.0% for control group; 40.7±4.4% for the group 1 received resveratrol; 41.6±4.8% for the group 2 received resveratroloside). The cardioprotective effect of resveratroloside was detected for the first time.

Keywords: Cardiovascular disease, in vivo experiments, ischemia-reperfusion, myocardial infarction, myocardial ischemia, natural stilbenes, Pinus sibirica, preconditioning, resveratrol, resveratroloside.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [207 - 210]
Pages: 4
DOI: 10.2174/187152571103140120103302
Price: $58

Article Metrics

PDF: 18